Abstract
RNA polymerase (pol) III synthesizes a range of essential products, including tRNA, 5S rRNA and 7SL RNA, which are required for protein synthesis and trafficking. High rates of pol III transcription are necessary for cells to sustain growth. A wide range of transformed and tumour cell types have been shown to express elevated levels of pol III products. This review will summarize what is known about the mechanisms responsible for this deregulation. Some transforming agents have been shown to stimulate expression of the pol III-specific transcription factors TFIIIB or TFIIIC2. In addition, TFIIIB is bound and activated by several oncogenic proteins, including c-Myc. Conversely, TFIIIB interacts in healthy cells with the tumour suppressors RB and p53. Indeed, the ability to limit pol III transcription through TFIIIB may contribute to their growth-suppression capacities. The function of p53 and/or RB is compromised in most if not all transformed cells; the resultant derepression of TFIIIB may provide an almost universal route to deregulate pol III transcription in cancers. In addition to effects on protein synthesis and growth, there is a precedent for a pol III product having oncogenic activity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Akusjarvi G, Svensson C and Nygard O . (1987). Mol. Cell. Biol., 7, 549–551.
Allende JE and Allende CC . (1995). FASEB J., 9, 313–323.
Altmann GG and Leblond CP . (1982). J. Cell Sci., 56, 83–99.
Arrand JR and Rymo L . (1982). J. Virol., 41, 376–389.
Bates S and Peters G . (1995). Semin. Cancer Biol., 6, 73–82.
Beier R, Burgin A, Kiermaier A, Fero M, Karsunky H, Saffrich R, Moroy T, Ansorge W, Roberts J and Eilers M . (2000). EMBO J., 19, 5813–5823.
Belenguer P, Baldin V, Mathieu C, Prats H, Bensaid M, Bouche G and Amalric F . (1989). Nucleic Acids Res., 17, 6625–6636.
Boon K, Caron HN, van Asperen R, Valentijn L, Hermus M-C, van Sluis P, Roobeek I, Weis I, Voute PA, Schwab M and Versteeg R . (2001). EMBO J., 20, 1383–1393.
Brandenburger Y, Jenkins A, Autelitano DJ and Hannan RD . (2001). FASEB J., 15, 2051–2053.
Brown TRP, Scott PH, Stein T, Winter AG and White RJ . (2000). Gene Expr., 9, 15–28.
Bullock AN, Henckel J and Fersht AR . (2000). Oncogene, 19, 1245–1256.
Busch H and Smetana K . (1970). The Nucleolus, Busch H, Smetana K. (eds). Academic Press: New York, pp 448–471.
Cairns CA and White RJ . (1998). EMBO J., 17, 3112–3123.
Cavanaugh AH, Hempel WM, Taylor LJ, Rogalsky V, Todorov G and Rothblum LI . (1995). Nature, 374, 177–180.
Chen W, Bocker W, Brosius J and Tiedge H . (1997a). J. Pathol., 183, 345–351.
Chen W, Heierhorst J, Brosius J and Tiedge H . (1997b). Eur. J. Cancer, 33, 288–292.
Chesnokov I, Chu W-M, Botchan MR and Schmid CW . (1996). Mol. Cell. Biol., 16, 7084–7088.
Chu W-M, Wang Z, Roeder RG and Schmid CW . (1997). J. Biol. Chem., 272, 14755–14761.
Ciarmatori S, Scott PH, Sutcliffe JE, McLees A, Alzuherri HM, Dannenberg J-H, Te Riele H, Grummt I, Voit R and White RJ . (2001). Mol. Cell Biol., 21, 5806–5814.
Clarke PA, Schwemmle M, Schickinger J, Hilse K and Clemens MJ . (1991). Nucleic Acids Res., 19, 243–248.
Clemens M . (1992). Nature, 360, 210–211.
Crighton D, Woiwode A, Zhang C, Mandavia N, Morton JP, Warnock LJ, Milner J, White RJ and Johnson DL . (2003). EMBO J., 22, 2810–2820.
Daly NL, Arvanitis DA, Fairley JA, Gomez-Roman N, Morton JP, Grahem SV, Spandidos DA and White RJ . Oncogene, Submitted.
Davies MV, Futrado M, Hershey JN, Thimmappaya B and Kaufman RJ . (1989). Proc. Natl. Acad. Sci. USA, 86, 9163–9167.
Derenzini M and Ploton D . (1994). Molecular Biology in Histopathology, Crocker J, (ed). Wiley and Sons Ltd: New York, pp 231–249.
DiCiommo D, Gallie BL and Bremner R . (2000). Semin. Cancer Biol., 10, 255–269.
Downward J . (2002). Nature Rev. Cancer, 3, 11–22.
Elia A, Laing KG, Schofield A, Tilleray VJ and Clemens MJ . (1996). Nucleic Acids Res., 24, 4471–4478.
Faust RA, Gapany M, Tristani P, Davis A, Adams GL and Ahmed K . (1996). Cancer Lett., 101, 31–35.
Felton-Edkins ZA, Fairley JA, Graham EL, Johnston IM, White RJ and Scott PH . (2003a). EMBO J., 22, 2422–2432.
Felton-Edkins ZA, Kenneth NS, Brown TRP, Daly NL, Gomez-Roman N, Grandori C, Eisenman RN and White RJ . (2003b). Cell Cycle, 3, 181–184.
Felton-Edkins ZA and White RJ . (2002). J. Biol. Chem., 277, 48182–48191.
Francis MA and Rajbhandary UL . (1990). Mol. Cell Biol., 10, 4486–4494.
Geiduschek EP and Kassavetis GA . (2001). J. Mol. Biol., 310, 1–26.
Ghavidel A and Schultz MC . (1997). Genes Dev., 11, 2780–2789.
Ghavidel A and Schultz MC . (2001). Cell, 106, 575–584.
Gomez-Roman N, Grandori C, Eisenman RN and White RJ . (2003). Nature, 421, 290–294.
Gottesfeld JM, Johnson DL and Nyborg JK . (1996). Mol. Cell Biol., 16, 1777–1785.
Grana X, Garriga J and Mayol X . (1998). Oncogene, 17, 3365–3383.
Hannan KM, Hannan RD, Smith SD, Jefferson LS, Lun M and Rothblum LI . (2000a). Oncogene, 19, 4988–4999.
Hannan KM, Kennedy BK, Cavanaugh AH, Hannan RD, Hirschler-Laszkiewicz I, Jefferson LS and Rothblum LI . (2000b). Oncogene, 19, 3487–3497.
Hannan RD, Hempel WM, Cavanaugh A, Arino T, Dimitrov SI, Moss T and Rothblum LI . (1998). J. Biol. Chem., 273, 1257–1267.
Harbour JW . (1998). Ophthamology, 105, 1442–1447.
Hernandez N . (1993). Genes Dev., 7, 1291–1308.
Hirama T and Koeffler HP . (1995). Blood, 86, 841–854.
Hirsch HA, Gu L and Henry RW . (2000). Mol. Cell Biol., 20, 9182–9191.
Hockman DJ and Schultz MC . (1996). Mol. Cell Biol., 16, 892–898.
Hoeffler WK, Kovelman R and Roeder RG . (1988). Cell, 53, 907–920.
Hoeffler WK and Roeder RG . (1985). Cell, 41, 955–963.
Hollstein M, Rice K, Greenblatt MS, Soussi T, Fucks R, Sorlie T, Hovig E, Smith-Sorensen B, Montesano R and Harris CC . (1994). Nucleic Acids Res., 22, 3551–3555.
Huang R, Wu T, Xu L, Liu A, Ji Y and Hu G . (2002). FASEB J., 16, 293–301.
Hunter T and Pines J . (1994). Cell, 79, 573–582.
Johnson LF, Abelson HT, Green H and Penman S . (1974). Cell, 1, 95–100.
Johnson SAS, Dubeau L, Kawalek M, Dervan A, Schonthal AH, Dang CV and Johnson DL . (2003). Mol. Cell Biol., 23, 3043–3051.
Johnson SAS, Mandavia N, Wang H-D and Johnson DL . (2000). Mol. Cell Biol., 20, 5000–5009.
Johnston IM, Allison SJ, Morton JP, Schramm L, Scott PH and White RJ . (2002). Mol. Cell Biol., 22, 3757–3768.
King RJB . (1996). Cancer Biol.. Longman: New York, pp 27–32.
Kitagawa N, Goto M, Kurozumi K, Maruo S, Fukayama M, Naoe T, Yasukawa M, Hino K, Suzuki T, Todo S and Takada K . (2000). EMBO J., 19, 6742–6750.
Klein J and Grummt I . (1999). Proc. Natl. Acad. Sci. USA, 96, 6096–6101.
Komano J, Maruo S, Kurozumi K, Oda T and Takada K . (1999). J. Virol., 73, 9827–9831.
Koromilas AE, Roy S, Barber GN, Katze MG and Sonenberg N . (1992). Science, 257, 1685–1689.
Kratzke RA, Otterson GA, Hogg A, Coxon AB, Geradts J, Cowell JK and Kaye FJ . (1994). Oncogene, 9, 1321–1326.
Kurata S, Koga K and Sakaguchi B . (1978). Chromosoma, 68, 313–317.
Laing KG, Matys V and Clemens MJ . (1995). Biochem. Soc. Trans., 23, 311S.
Larminie CGC, Cairns CA, Mital R, Martin K, Kouzarides T, Jackson SP and White RJ . (1997). EMBO J., 16, 2061–2071.
Larminie CGC, Sutcliffe JE, Tosh K, Winter AG, Felton-Edkins ZA and White RJ . (1999). Mol. Cell Biol., 19, 4927–4934.
Lengyel P . (1993). Proc. Natl. Acad. Sci. USA, 90, 5893–5895.
Liebhaber SA, Wolf S and Schlessinger D . (1978). Cell, 13, 121–127.
Litchfield DW and Luscher B . (1993). Mol. Cell. Biochem., 127/128, 187–199.
Mateyak MK, Obaya AJ, Adachi S and Sedivy JM . (1997). Cell Growth Differ., 8, 1039–1048.
Mauck JC and Green H . (1974). Cell, 3, 171–177.
Meurs EF, Galabru J, Barber GN, Katze MG and Hovanessian AG . (1993). Proc. Natl. Acad. Sci. USA, 90, 232–236.
Moss T and Stefanovsky VY . (1995). Prog. Nucleic Acid Res. Mol. Biol., 50, 25–66.
Mulligan G and Jacks T . (1998). Trends Genet., 14, 223–229.
Munstermann U, Fritz G, Seitz G, Lu YP, Schneider HR and Issinger OG . (1990). Eur. J. Biochem., 189, 251–257.
Nanbo A, Inoue K, Adachi-Takasawa K and Takada K . (2002). EMBO J., 21, 954–965.
Nasmyth K . (1996). Nature, 382, 28–29.
Nesbit CE, Tersak JM and Prochownik EV . (1999). Oncogene, 18, 3004–3016.
Neufeld TP, de la Cruz AF, Johnston LA and Edgar BA . (1998). Cell, 93, 1183–1193.
Neufeld TP and Edgar BA . (1998). Curr. Opin. Cell Biol., 10, 784–790.
Notterman DA, Alon U, Sierk AJ and Levine AJ . (2001). Cancer Res., 61, 3124–3130.
Oren M . (1999). J. Biol. Chem., 274, 36031–36034.
Pelletier G, Stefanovsky VY, Faubladier M, Hirschler-Laszkiewicz I, Savard J, Rothblum LI, Cote J and Moss T . (2000). Mol. Cell, 6, 1059–1066.
Pianese G . (1896). Beitr. Pathol. Anat. Allgem. Pathol., 142, 1–193.
Pombo A, Jackson DA, Hollinshead M, Wang Z, Roeder RG and Cook PR . (1999). EMBO J., 18, 2241–2253.
Rocco JW and Sidransky D . (2001). Exp. Cell Res., 264, 42–55.
Ruf IK, Rhyne PW, Yang C, Cleveland JL and Sample JT . (2000). J. Virol., 74, 10223–10228.
Ruggero D and Pandolfi PP . (2003). Nature Rev. Cancer, 3, 179–192.
Schramm L and Hernandez N . (2002). Genes Dev., 16, 2593–2620.
Schwartz LB, Sklar VEF, Jaehning SJ, Weinmann R and Roeder RG . (1974). J. Biol. Chem., 249, 5889–5897.
Scott MRD, Westphal K-H and Rigby PWJ . (1983). Cell, 34, 557–567.
Scott PH, Cairns CA, Sutcliffe JE, Alzuherri HM, Mclees A, Winter AG and White RJ . (2001). J. Biol. Chem., 276, 1005–1014.
Seldin DC and Leder P . (1995). Science, 267, 894–897.
Sellers WR, Novitch BG, Miyake S, Heith A, Otterson GA, Kaye FJ, Lassar AB and Kaelin WG . (1998). Genes Dev., 12, 95–106.
Sharp TV, Schwemmle M, Jeffrey I, Laing K, Mellor H, Proud CG, Hilse K and Clemens MJ . (1993). Nucleic Acids Res., 21, 4483–4490.
Sherr CJ . (2001). Nat. Rev. Mol. Cell. Biol., 2, 731–737.
Stefanovsky VY, Pelletier G, Hannan R, Gagnon-Kugler T, Rothblum LI and Moss T . (2001). Mol. Cell., 8, 1063–1073.
Stein T, Crighton D, Boyle JM, Varley JM and White RJ . (2002a). Oncogene, 21, 2961–2970.
Stein T, Crighton D, Warnock LJ, Milner J and White RJ . (2002b). Oncogene, 21, 5540–5547.
Sugimoto M, Kuo M-L, Roussel MF and Sherr CJ . (2003). Mol. Cell, 11, 415–424.
Sutcliffe JE . (2000). PhD thesis. University of Glasgow.
Sutcliffe JE, Brown TRP, Allison SJ, Scott PH and White RJ . (2000). Mol. Cell Biol., 20, 9192–9202.
Sutcliffe JE, Cairns CA, McLees A, Allison SJ, Tosh K and White RJ . (1999). Mol. Cell Biol., 19, 4255–4261.
Thimmappaya B, Weinberger C, Schneider RJ and Shenk T . (1982). Cell, 31, 543–551.
Voit R and Grummt I . (2001). Proc. Natl. Acad. Sci. USA, 98, 13631–13636.
Voit R, Kuhn A, Sander EE and Grummt I . (1995). Nucleic Acids Res., 23, 2593–2599.
Voit R, Schafer K and Grummt I . (1997). Mol. Cell Biol., 17, 4230–4237.
Voit R, Schnapp A, Kuhn A, Rosenbauer H, Hirschmann P, Stunnenberg HG and Grummt I . (1992). EMBO J., 11, 2211–2218.
Vousden KH . (1995). Semin. Cancer Biol., 6, 109–116.
Wang, H-D, Trivedi A and Johnson DL . (1997). Mol. Cell Biol., 17, 6838–6846.
Wang, H-D, Trivedi A and Johnson DL . (1998). Mol. Cell Biol., 18, 7086–7094.
Wang H-D, Yuh C-H, Dang CV and Johnson DL . (1995). Mol. Cell Biol., 15, 6720–6728.
Warner JR . (1999). Trends Biochem. Sci., 24, 437–440.
Weinberg RA . (1995). Cell, 81, 323–330.
Whitaker LL, Su H, Baskaran R, Knudsen ES and Wang JYJ . (1998). Mol. Cell. Biol., 18, 4032–4042.
White RJ . (1997). Trends Biochem. Sci., 22, 77–80.
White RJ . (2002). Landes Bioscience, Austin http://www.eurekah.com.
White RJ . (2004). In Cell Growth Control, (eds) Hall M, Raff M, and Thomas G. Cold Spring Harbor Laboratory Press.: Cold Spring Harbour, New York.
White RJ, Gottlieb TM, Downes CS and Jackson SP . (1995). Mol. Cell Biol., 15, 6653–6662.
White RJ, Stott D and Rigby PWJ . (1990). EMBO J., 9, 3713–3721.
White RJ, Trouche D, Martin K, Jackson SP and Kouzarides T . (1996). Nature, 382, 88–90.
Winter AG, Sourvinos G, Allison SJ, Tosh K, Scott PH, Spandidos DA and White RJ . (2000). Proc. Natl. Acad. Sci. USA, 97, 12619–12624.
Yamamoto N, Takizawa T, Iwanaga Y, Shimizu N and Yamamoto N . (2000). FEBS Lett., 484, 153–158.
Ying C, Gregg DW and Gorski J . (1996). Mol. Cell Endocrinol., 118, 207–213.
Yoshinaga S, Dean N, Han M and Berk AJ . (1986). EMBO J., 5, 343–354.
Zhai W and Comai L . (1999). Mol. Cell Biol., 19, 2791–2802.
Zhai W and Comai L . (2000). Mol. Cell Biol., 20, 5930–5938.
Zhao J, Yuan X, Frodin M and Grummt I . (2003). Mol. Cell, 11, 405–413.
zur Hausen H . (2000). J. Nat. Cancer Inst., 92, 690–698.
zur Hausen H . (2002). Nat. Rev Cancer, 2, 342–350.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is cited by
-
Biallelic variants in GTF3C5, a regulator of RNA polymerase III-mediated transcription, cause a multisystem developmental disorder
Human Genetics (2024)
-
Codon optimality in cancer
Oncogene (2021)
-
Integrated genomic analysis reveals regulatory pathways and dynamic landscapes of the tRNA transcriptome
Scientific Reports (2021)
-
miRNA deregulation targets specific pathways in leiomyosarcoma development: an in silico analysis
Journal of Translational Medicine (2019)
-
Inhibition of RNA polymerase III transcription by Triptolide attenuates colorectal tumorigenesis
Journal of Experimental & Clinical Cancer Research (2019)